Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Vranckx

Showing results (141-150 of 305) with videos related to

Pageof 31
Sort By:
JACC. Cardiovascular Imaging|July 3, 2025
Evolution and Clinical Relevance of Left Atrial Appendage Residual Patency After Percutaneous Closure: A Prespecified Analysis of the SWISS-APERO TrialRoberto Galea, Juan Perich Krsnik, Alan Arthur Peters, et al.
European Heart Journal. Cardiovascular Imaging|August 12, 2025
Incidence and Predictors of Persistent Left Atrial Appendage Patency and its Subtypes after Percutaneous Closure: a Pre-Specified Analysis of the SWISS-APERO TrialRoberto Galea, Juan Perich Krsnik, Alan Arthur Peters, et al.
European Heart Journal|July 15, 2015
Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research ConsortiumGregg W Stone, David H Adams, William T Abraham, et al.
Journal of the American College of Cardiology|July 18, 2015
Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research ConsortiumGregg W Stone, David H Adams, William T Abraham, et al.
Journal of the American College of Cardiology|February 23, 2010
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesionsPatrick W Serruys, Yoshinobu Onuma, Scot Garg, et al.
Circulation|August 16, 2020
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER TrialGiuseppe Gargiulo, Giovanni Esposito, Marisa Avvedimento, et al.
Acta Cardiologica|September 4, 2009
Implementation of reperfusion therapy in ST-segment elevation myocardial infarction. A policy statement from the Belgian Society of Cardiology (BSC), the Belgian Interdisciplinary Working Group on Acute Cardiology (BIWAC) and the Belgian Working Group on Interventional Cardiology (BWGIC)Marc J Claeys, Sofie Gevaert, Antoine De Meester, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 9, 2022
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trialMasafumi Ono, Hironori Hara, Hideyuki Kawashima, et al.
European Journal of Internal Medicine|May 4, 2024
Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trialAntonio Landi, Dik Heg, Enrico Frigoli, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 27, 2013
Reperfusion therapy and mortality in octogenarian STEMI patients: results from the Belgian STEMI registryEls H Vandecasteele, Marc De Buyzere, Sofie Gevaert, et al.
Pageof 31

Showing results (141-150 of 305) with videos related to

Sort By:
Pageof 31
JACC. Cardiovascular Imaging|July 3, 2025
Evolution and Clinical Relevance of Left Atrial Appendage Residual Patency After Percutaneous Closure: A Prespecified Analysis of the SWISS-APERO TrialRoberto Galea, Juan Perich Krsnik, Alan Arthur Peters, et al.
European Heart Journal. Cardiovascular Imaging|August 12, 2025
Incidence and Predictors of Persistent Left Atrial Appendage Patency and its Subtypes after Percutaneous Closure: a Pre-Specified Analysis of the SWISS-APERO TrialRoberto Galea, Juan Perich Krsnik, Alan Arthur Peters, et al.
European Heart Journal|July 15, 2015
Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research ConsortiumGregg W Stone, David H Adams, William T Abraham, et al.
Journal of the American College of Cardiology|July 18, 2015
Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research ConsortiumGregg W Stone, David H Adams, William T Abraham, et al.
Journal of the American College of Cardiology|February 23, 2010
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesionsPatrick W Serruys, Yoshinobu Onuma, Scot Garg, et al.
Circulation|August 16, 2020
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER TrialGiuseppe Gargiulo, Giovanni Esposito, Marisa Avvedimento, et al.
Acta Cardiologica|September 4, 2009
Implementation of reperfusion therapy in ST-segment elevation myocardial infarction. A policy statement from the Belgian Society of Cardiology (BSC), the Belgian Interdisciplinary Working Group on Acute Cardiology (BIWAC) and the Belgian Working Group on Interventional Cardiology (BWGIC)Marc J Claeys, Sofie Gevaert, Antoine De Meester, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 9, 2022
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trialMasafumi Ono, Hironori Hara, Hideyuki Kawashima, et al.
European Journal of Internal Medicine|May 4, 2024
Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trialAntonio Landi, Dik Heg, Enrico Frigoli, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 27, 2013
Reperfusion therapy and mortality in octogenarian STEMI patients: results from the Belgian STEMI registryEls H Vandecasteele, Marc De Buyzere, Sofie Gevaert, et al.
Pageof 31